ResearcherLyon 1 UniversitéNo recent work listed
Emmet McCormack
Matched on ORCID iD 0000-0002-7621-4625; OpenAlex author ID A5006949480. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 15
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 3 papers · 2021: 1 paper · 2022: 1 paper
Papers 8
- SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma? Last author DOI 10.3390/pharmaceutics14010098↗
- Selecting the optimal parameters for sonoporation of pancreatic cancer in a pre-clinical model. Co-author DOI 10.1080/15384047.2021.1881026↗
- Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines. Co-author DOI 10.1124/dmd.119.089334↗
- Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells. Last author DOI 10.3390/pharmaceutics12020141↗
- Low-Intensity Sonoporation-Induced Intracellular Signalling of Pancreatic Cancer Cells, Fibroblasts and Endothelial Cells. Last author DOI 10.3390/pharmaceutics12111058↗
- Sonoporation with Acoustic Cluster Therapy (ACT®) induces transient tumour volume reduction in a subcutaneous xenograft model of pancreatic ductal adenocarcino… Last author DOI 10.1016/j.jconrel.2016.11.019↗
- A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2016.10.007↗
- Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft. Last author DOI 10.1007/s11307-013-0672-5↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Spiros Kotopoulis · 8 shared papers, 2014–2022 · strength 0.74
- Paper SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarc… DOI 10.3390/pharmaceutics14010098↗
- Paper Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells. DOI 10.3390/pharmaceutics12020141↗
- Paper Low-Intensity Sonoporation-Induced Intracellular Signalling of Pancreatic Cancer Cells, Fibroblasts and Endothelial Cel… DOI 10.3390/pharmaceutics12111058↗
- Odd Helge Gilja · 6 shared papers, 2014–2022 · strength 0.54
- Paper SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarc… DOI 10.3390/pharmaceutics14010098↗
- Paper Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells. DOI 10.3390/pharmaceutics12020141↗
- Paper Low-Intensity Sonoporation-Induced Intracellular Signalling of Pancreatic Cancer Cells, Fibroblasts and Endothelial Cel… DOI 10.3390/pharmaceutics12111058↗
- Tormod Karlsen Bjånes · 4 shared papers, 2016–2022 · strength 0.42
- Paper SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarc… DOI 10.3390/pharmaceutics14010098↗
- Paper Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells. DOI 10.3390/pharmaceutics12020141↗
- Paper Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines. DOI 10.1124/dmd.119.089334↗
- Ragnhild Haugse · 2 shared papers, 2020–2022 · strength 0.26
- Paper SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarc… DOI 10.3390/pharmaceutics14010098↗
- Paper Low-Intensity Sonoporation-Induced Intracellular Signalling of Pancreatic Cancer Cells, Fibroblasts and Endothelial Cel… DOI 10.3390/pharmaceutics12111058↗
- Georg Gjorgji Dimcevski · 3 shared papers, 2014–2022 · strength 0.24
- Paper SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarc… DOI 10.3390/pharmaceutics14010098↗
- Paper A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic canc… DOI 10.1016/j.jconrel.2016.10.007↗
- Paper Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenog… DOI 10.1007/s11307-013-0672-5↗
- Bettina Riedel · 2 shared papers, 2020 · strength 0.22
- Lars Petter Jordheim · 1 shared paper, 2020 · strength 0.11
- John Robert Eisenbrey · 1 shared paper, 2021 · strength 0.10
- Flemming Forsberg · 1 shared paper, 2021 · strength 0.10
- Teena Dhir · 1 shared paper, 2021 · strength 0.10
- Christopher William Schultz · 1 shared paper, 2021 · strength 0.10
- Jonathan Robert Brody · 1 shared paper, 2021 · strength 0.10
- Michiel Postema · 2 shared papers, 2014–2016 · strength 0.10
- Paper A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic canc… DOI 10.1016/j.jconrel.2016.10.007↗
- Paper Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenog… DOI 10.1007/s11307-013-0672-5↗
- Dag Hoem · 1 shared paper, 2016 · strength 0.05
- Anders Molven · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.